Diffuse alveolar haemorrhage as a rare complication of antiphospholipid syndrome

Diffuse alveolar haemorrhage as a rare complication of antiphospholipid syndrome

Diffuse alveolar haemorrhage (DAH) is a rare complication of antiphospholipid syndrome. With a mortality rate of 46%, early diagnosis and management remain an ongoing challenge. Case reports are limited, and management guidelines are not yet definitive. In this case report, we present a 43-year-old...

Full description

Bibliographic Details
Main Authors: Bhagavata Srinivasan, S.P (Author), Bulloch, G. (Author), Corte, T.J (Author), Frankel, A. (Author), Garsia, R. (Author), Hsu, K. (Author), Passam, F. (Author), Seth, I. (Author), Yi, D.S (Author)
Format: Article
Language:English
Published: John Wiley and Sons Inc 2022
Subjects:
antiphospholipid antibodies
antiphospholipid syndrome
APS
complication
diffuse alveolar haemorrhage
rare
Online Access:View Fulltext in Publisher
Description
Summary:Diffuse alveolar haemorrhage (DAH) is a rare complication of antiphospholipid syndrome. With a mortality rate of 46%, early diagnosis and management remain an ongoing challenge. Case reports are limited, and management guidelines are not yet definitive. In this case report, we present a 43-year-old male with DAH who required high-dose oral steroids, intravenous methylprednisolone cyclophosphamide and rituximab over 18 months to control life-threatening episodes of pulmonary bleeding. © 2022 The Authors. Respirology Case Reports published by John Wiley & Sons Australia, Ltd on behalf of The Asian Pacific Society of Respirology.
ISBN:20513380 (ISSN)
DOI:10.1002/rcr2.948

Similar Items